JP2009510051A5 - - Google Patents

Download PDF

Info

Publication number
JP2009510051A5
JP2009510051A5 JP2008532961A JP2008532961A JP2009510051A5 JP 2009510051 A5 JP2009510051 A5 JP 2009510051A5 JP 2008532961 A JP2008532961 A JP 2008532961A JP 2008532961 A JP2008532961 A JP 2008532961A JP 2009510051 A5 JP2009510051 A5 JP 2009510051A5
Authority
JP
Japan
Prior art keywords
composition according
disease
composition
inflammatory
inflammatory disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008532961A
Other languages
English (en)
Japanese (ja)
Other versions
JP5331962B2 (ja
JP2009510051A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2006/053540 external-priority patent/WO2007036900A2/en
Publication of JP2009510051A publication Critical patent/JP2009510051A/ja
Publication of JP2009510051A5 publication Critical patent/JP2009510051A5/ja
Application granted granted Critical
Publication of JP5331962B2 publication Critical patent/JP5331962B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008532961A 2005-09-30 2006-09-28 炎症性疾患のための薬草組成物 Expired - Fee Related JP5331962B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN1226MU2005 2005-09-30
IN1226/MUM/2005 2005-09-30
US73644305P 2005-11-14 2005-11-14
US60/736,443 2005-11-14
PCT/IB2006/053540 WO2007036900A2 (en) 2005-09-30 2006-09-28 Herbal composition for inflammatory disorders

Publications (3)

Publication Number Publication Date
JP2009510051A JP2009510051A (ja) 2009-03-12
JP2009510051A5 true JP2009510051A5 (cg-RX-API-DMAC7.html) 2009-10-01
JP5331962B2 JP5331962B2 (ja) 2013-10-30

Family

ID=37900158

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008532961A Expired - Fee Related JP5331962B2 (ja) 2005-09-30 2006-09-28 炎症性疾患のための薬草組成物

Country Status (10)

Country Link
US (2) US7635494B2 (cg-RX-API-DMAC7.html)
EP (1) EP1931366B1 (cg-RX-API-DMAC7.html)
JP (1) JP5331962B2 (cg-RX-API-DMAC7.html)
AU (1) AU2006296197B2 (cg-RX-API-DMAC7.html)
CA (1) CA2624049C (cg-RX-API-DMAC7.html)
EA (1) EA014070B1 (cg-RX-API-DMAC7.html)
GE (1) GEP20115332B (cg-RX-API-DMAC7.html)
MA (1) MA29890B1 (cg-RX-API-DMAC7.html)
PL (1) PL1931366T3 (cg-RX-API-DMAC7.html)
WO (1) WO2007036900A2 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8981131B2 (en) * 2007-07-27 2015-03-17 Piramal Enterprises Limited Tricyclic compounds for the treatment of inflammatory disorders
WO2009084032A2 (en) * 2007-12-03 2009-07-09 Vedic Elements Private Limited Stable hydrophobic topical herbal formulation
WO2012014216A1 (en) * 2010-07-28 2012-02-02 Laila Nutraceuticals 7-hydroxyfrullanolide and its analogs for prevention, control and treatment of metabolic disorders
US10105347B2 (en) 2009-02-02 2018-10-23 Laila Nutraceuticals Sphaeranthus indicus derived ingredients and their compositions for enhancing physical performance and energy levels
CN102292093B (zh) * 2009-02-02 2015-01-28 莱拉营养食品有限公司 用于代谢综合症控制的选自绒毛戴星草和莽吉柿的混合物
WO2011033524A2 (en) * 2009-08-04 2011-03-24 Laila Nutraceuticals Agents from ficus hispida for the amelioration of metabolic syndrome and related diseases
WO2011083397A1 (en) * 2010-01-05 2011-07-14 Himalaya Global Holdings Limited Herbal composition for skin disorders
PH12013500451A1 (en) * 2010-09-11 2013-05-20 Laila Nutraceuticals Sphaeranthus indicus derived ingredients and their compositions for enhancing physical performance and energy levels
US8263579B2 (en) * 2011-01-24 2012-09-11 Piramal Healthcare Limited Anti-inflammatory compounds
TW201427677A (zh) * 2012-10-23 2014-07-16 Piramal Entpr Ltd 用於預防及治療腫瘤壞死因子-α媒介疾病中藥組合物
EP3313384A4 (en) 2015-06-23 2019-04-03 Nobilis Therapeutics, Inc. THERAPEUTIC IMMUNE MODULATION USING NOBLE GAS COMPOSITIONS
WO2017203540A1 (en) * 2016-05-21 2017-11-30 Laila Impex Dietary supplements and compositions for enhancing physical performance and energy levels

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646687A (en) * 1994-12-29 1997-07-08 Lucent Technologies Inc. Temporally-pipelined predictive encoder/decoder circuit and method
US6204523B1 (en) * 1998-11-06 2001-03-20 Lumileds Lighting, U.S., Llc High stability optical encapsulation and packaging for light-emitting diodes in the green, blue, and near UV range
US6686676B2 (en) * 2001-04-30 2004-02-03 General Electric Company UV reflectors and UV-based light sources having reduced UV radiation leakage incorporating the same
US6989412B2 (en) * 2001-06-06 2006-01-24 Henkel Corporation Epoxy molding compounds containing phosphor and process for preparing such compositions
US6841647B2 (en) * 2001-11-06 2005-01-11 National Starch And Chemical Investment Holding Corporation Fluid resistant silicone encapsulant
US7160972B2 (en) * 2003-02-19 2007-01-09 Nusil Technology Llc Optically clear high temperature resistant silicone polymers of high refractive index
US7261441B2 (en) * 2004-02-27 2007-08-28 Avago Technologies Ecbu Ip (Singapore) Pte. Ltd. LED device and method for directing LED light
WO2006016228A2 (en) * 2004-08-02 2006-02-16 Prashanth Kumar V Cytotoxic peptide alkaloid and pharmaceutical compositions for the treatment of neoplastic diseases
US7229934B2 (en) * 2004-10-18 2007-06-12 International Business Machines Corporation Porous organosilicates with improved mechanical properties

Similar Documents

Publication Publication Date Title
RU2001134300A (ru) Фармацевтические и пищевые композиции, содержащие незаменимые жирные кислоты и гомоцистеин-понижающие агенты
US6166077A (en) Use of L-acetylcarnitine, L-isovalerylcarnitine, L-propionylcarnitine for increasing the levels of IGF-1
WO2014019268A1 (zh) 一种促进神经损伤修复的药物组合物及其应用
JP2025157438A5 (cg-RX-API-DMAC7.html)
JP2016519101A (ja) オメガ−3脂肪酸およびトマトリコペンを含む抗炎症性相乗的組み合わせ
JP2003530349A (ja) 皮膚病用の使用方法及び皮膚病用薬剤
AU2017287746A1 (en) Optically active pyranochromenyl phenol derivative and pharmaceutical composition comprising same
KR20150011379A (ko) 옥시부티닌 투여를 위한 방법 및 조성물
CN101654393A (zh) 作为肝脏保护剂的化合物和组合物
CN113546089A (zh) 1-乙基-3,7-二甲基黄嘌呤在制备治疗肺炎药物中的应用
CN118490680B (zh) 瑞香素在制备治疗病毒性肺炎的药物中的应用
RU2006133305A (ru) Применение 2, 5-дигидроксибензолсульфоновой кислоты для получения лекарственных препаратов, применяемых для лечения ангиозависимых заболеваний
FI4199922T3 (fi) (1r,3s)-3-((5-syano-4-fenyylitiatsol-2-yyli)karbamoyyli)syklopentaani-1-karboksyylihappo käytettäväksi hengitystietautien hoidossa
CN112972391A (zh) 一种胆红素-jph203纳米颗粒及其制备和应用
CN109260217A (zh) 3`-脱氧次黄嘌呤核苷在制备用于多种疾病药品、食品或保健品中的应用
CN105412118A (zh) 治疗急慢性呼吸困难的西药组合物及其制备方法
CN103301118A (zh) 注射用精氨酸布洛芬组合物
CN104000822A (zh) 一种含有比拉斯汀的复方感冒药物组合物
CN109464441B (zh) 3-乙酰氨基香豆素在制备治疗或预防高尿酸血症及肾损伤的药物中的应用
JP6188784B2 (ja) 炎症性および免疫性疾患の治療のための組成物
Aggarwal et al. Thalidomide-The disastrous drug
RU2006140277A (ru) Незаменимые жирные кислоты, предназначенные для предупреждения и/или лечения депрессии у пациентов, страдающих коронарной болезнью коронарной артерии
US20260102376A1 (en) Use of dihydrotanshinone i derivative in preparation of drug for treating cerebral cavernous malformation
US20040092592A1 (en) Stabilized L-Arginine platelet aggregation inhibitory compositions and processes for making same
CN102283982B (zh) 一种治疗体癣的药物组合物